Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

Name: Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)
License: Public Domain

Merck Sharp & Dohme LLC

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

cervical cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 353417
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.